老虎證券
Invest
Pricing
Rewards
Support
Learn
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
APRINOIA Therapeutics Inc.
成交量:
- -
成交額:
- -
市值:
- -
市盈率:
- -
高:
- -
開:
- -
低:
- -
收:
0.2201
52周最高:
- -
52周最低:
- -
股本:
2,686.12萬
流通股本:
50.00萬
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
-285.76%
市淨率:
0.00
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字:
APRINOIA Therapeutics Inc.
交易所:
NASDAQ
成立時間:
- -
員工人數:
- -
公司地址:
- -
官網:
http://www.aprinoia.com
郵編:
- -
電話:
- -
傳真:
- -
簡介:
Aprinoia Therapeutics Inc.成立於開曼群島。該公司是一家臨床階段的生物技術公司,致力於通過開發新穎、高靈敏度和選擇性的診斷工具和新型治療方法,保護患者的大腦健康,改變各種神經退行性疾病的臨床結果。他們的名字,APRINOIA,合併了拉丁語“杏”,意思是陽光,和希臘語後綴“noia”,意思是頭腦,反映了他們的使命,即揭示更好地診斷和治療可怕的神經退行性疾病的方法,並希望通過新的診斷工具和靶向治療為全世界的患者提供更光明的未來。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/APRI/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"APRI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APRI\",,,,,undefined,":{"symbol":"APRI","market":"US","secType":"STK","nameCN":"APRINOIA Therapeutics Inc.","latestPrice":0,"timestamp":0,"preClose":0.2201,"halted":9,"volume":0,"delay":0,"changeRate":-1,"floatShares":500000,"shares":26861214,"eps":0,"marketStatus":"盤後交易","change":-0.2201,"latestTime":"02-24 17:00:17 EST","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1771981200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1729828800000,"exchange":"NASDAQ","adjPreClose":0.2201,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APRI\",,,,,undefined,":{"symbol":"APRI","floatShares":500000,"roa":"-285.76%","roe":"--","lyrEps":0,"shares":26861214,"dividePrice":0,"high":0,"amplitude":0,"preClose":0.2201,"low":0,"week52Low":0,"pbRate":"0.00","psRate":"0.00","week52High":0,"institutionHeld":0.1597,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APRI\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APRI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APRI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.aprinoia.com","compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Aprinoia Therapeutics Inc.成立於開曼群島。該公司是一家臨床階段的生物技術公司,致力於通過開發新穎、高靈敏度和選擇性的診斷工具和新型治療方法,保護患者的大腦健康,改變各種神經退行性疾病的臨床結果。他們的名字,APRINOIA,合併了拉丁語“杏”,意思是陽光,和希臘語後綴“noia”,意思是頭腦,反映了他們的使命,即揭示更好地診斷和治療可怕的神經退行性疾病的方法,並希望通過新的診斷工具和靶向治療為全世界的患者提供更光明的未來。","yearOnYearQuotes":[{"month":1,"riseRate":0.777778,"avgChangeRate":0.231635},{"month":2,"riseRate":0.5,"avgChangeRate":0.02312},{"month":3,"riseRate":0.125,"avgChangeRate":-0.236856},{"month":4,"riseRate":0.375,"avgChangeRate":-0.086068},{"month":5,"riseRate":0.5,"avgChangeRate":-0.041745},{"month":6,"riseRate":0.5,"avgChangeRate":0.077177},{"month":7,"riseRate":0.125,"avgChangeRate":-0.086429},{"month":8,"riseRate":0.625,"avgChangeRate":0.050943},{"month":9,"riseRate":0.375,"avgChangeRate":-0.055461},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.041661},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.01061},{"month":12,"riseRate":0.444444,"avgChangeRate":-0.013035}],"exchange":"NASDAQ","name":"APRINOIA Therapeutics Inc.","nameEN":"APRINOIA Therapeutics Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"APRI\",market:\"US\",,,undefined,":null}}